Mechanisms of Transcriptional Regulation by P53

Overview

Journal Cell Death Differ

Specialty Cell Biology

Date 2017 Nov 11

PMID 29125602

Citations 227

Authors

Kelly D Sullivan

Matthew D Galbraith

Zdenek Andrysik

Joaquin M Espinosa

Affiliations

Soon will be listed here.

Abstract

p53 is a transcription factor that suppresses tumor growth through regulation of dozens of target genes with diverse biological functions. The activity of this master transcription factor is inactivated in nearly all tumors, either by mutations in the TP53 locus or by oncogenic events that decrease the activity of the wild-type protein, such as overexpression of the p53 repressor MDM2. However, despite decades of intensive research, our collective understanding of the p53 signaling cascade remains incomplete. In this review, we focus on recent advances in our understanding of mechanisms of p53-dependent transcriptional control as they relate to five key areas: (1) the functionally distinct N-terminal transactivation domains, (2) the diverse regulatory roles of its C-terminal domain, (3) evidence that p53 is solely a direct transcriptional activator, not a direct repressor, (4) the ability of p53 to recognize many of its enhancers across diverse chromatin environments, and (5) mechanisms that modify the p53-dependent transcriptional program in a context-dependent manner.

Citing Articles

p53 regulates DREAM complex-mediated repression in a p21-independent manner.

Agrawal R, Sengupta S EMBO J. 2025; .

PMID: 40038454 DOI: 10.1038/s44318-025-00402-7.

CTCF/RAD21 organize the ground state of chromatin-nuclear speckle association.

Yu R, Roseman S, Siegenfeld A, Gardner Z, Nguyen S, Tran K Nat Struct Mol Biol. 2025; .

PMID: 39984730 DOI: 10.1038/s41594-024-01465-6.

TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis.

Li J, Bai L, Xin Z, Song J, Chen H, Song X Sci Rep. 2025; 15(1):3620.

PMID: 39880909 PMC: 11779956. DOI: 10.1038/s41598-025-87545-z.

How can HPV E6 manipulate host cell differentiation process to maintain the reservoir of infection.

Chen Y, Egawa N, Zheng K, Doorbar J Tumour Virus Res. 2025; 19:200313.

PMID: 39832674 PMC: 11847044. DOI: 10.1016/j.tvr.2025.200313.

Genome-Wide Analysis of p53 Targets Reveals SCN2A as a Novel Player in p53-Induced Cell Arrest in HPV-Positive Cells.

Zhang Y, Liu Y, Xing X, Liu H, Guan W Viruses. 2024; 16(11).

PMID: 39599840 PMC: 11598893. DOI: 10.3390/v16111725.

References

Laptenko O, Prives C . Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ. 2006; 13(6):951-61. DOI: 10.1038/sj.cdd.4401916. View

Gallant-Behm C, Espinosa J . ΔNp63α utilizes multiple mechanisms to repress transcription in squamous cell carcinoma cells. Cell Cycle. 2013; 12(3):409-16. PMC: 3587441. DOI: 10.4161/cc.23593. View

Kaeser M, Iggo R . Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc Natl Acad Sci U S A. 2002; 99(1):95-100. PMC: 117520. DOI: 10.1073/pnas.012283399. View

FERGUSON A, Evron E, Umbricht C, Pandita T, Chan T, Hermeking H . High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A. 2000; 97(11):6049-54. PMC: 18556. DOI: 10.1073/pnas.100566997. View

Raycroft L, Wu H, Lozano G . Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science. 1990; 249(4972):1049-51. PMC: 2935288. DOI: 10.1126/science.2144364. View

Laptenko O, Beckerman R, Freulich E, Prives C . p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation. Proc Natl Acad Sci U S A. 2011; 108(26):10385-90. PMC: 3127872. DOI: 10.1073/pnas.1105680108. View

Lee K, Crowe A, Barton M . p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding. Mol Cell Biol. 1999; 19(2):1279-88. PMC: 116057. DOI: 10.1128/MCB.19.2.1279. View

Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman W . Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 2000; 14(8):981-93. PMC: 316542. View

White D, Talbott K, Arva N, Bargonetti J . Mouse double minute 2 associates with chromatin in the presence of p53 and is released to facilitate activation of transcription. Cancer Res. 2006; 66(7):3463-70. DOI: 10.1158/0008-5472.CAN-05-1381. View

10.

Fischer M, Quaas M, Nickel A, Engeland K . Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex. Oncotarget. 2015; 6(39):41402-17. PMC: 4747163. DOI: 10.18632/oncotarget.6356. View

11.

Laptenko O, Shiff I, Freed-Pastor W, Zupnick A, Mattia M, Freulich E . The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domain. Mol Cell. 2015; 57(6):1034-1046. PMC: 6221458. DOI: 10.1016/j.molcel.2015.02.015. View

12.

Gomes N, Espinosa J . Differential regulation of p53 target genes: it's (core promoter) elementary. Genes Dev. 2010; 24(2):111-4. PMC: 2807345. DOI: 10.1101/gad.1893610. View

13.

Fischer M, Quaas M, Steiner L, Engeland K . The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes. Nucleic Acids Res. 2015; 44(1):164-74. PMC: 4705690. DOI: 10.1093/nar/gkv927. View

14.

DRANE P, Barel M, Balbo M, Frade R . Identification of RB18A, a 205 kDa new p53 regulatory protein which shares antigenic and functional properties with p53. Oncogene. 1998; 15(25):3013-24. DOI: 10.1038/sj.onc.1201492. View

15.

Ogden S, Lee K, Stratton S, Aronow B, Barton M . p53 targets chromatin structure alteration to repress alpha-fetoprotein gene expression. J Biol Chem. 2001; 276(45):42057-62. DOI: 10.1074/jbc.C100381200. View

16.

Lowe E, Tews I, Cheng K, Brown N, Gul S, Noble M . Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. Biochemistry. 2002; 41(52):15625-34. DOI: 10.1021/bi0268910. View

17.

Murphy M, Ahn J, Walker K, Hoffman W, Evans R, Levine A . Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev. 1999; 13(19):2490-501. PMC: 317076. DOI: 10.1101/gad.13.19.2490. View

18.

Verfaillie A, Svetlichnyy D, Imrichova H, Davie K, Fiers M, Atak Z . Multiplex enhancer-reporter assays uncover unsophisticated TP53 enhancer logic. Genome Res. 2016; 26(7):882-95. PMC: 4937571. DOI: 10.1101/gr.204149.116. View

19.

Tafvizi A, Huang F, Leith J, Fersht A, Mirny L, van Oijen A . Tumor suppressor p53 slides on DNA with low friction and high stability. Biophys J. 2008; 95(1):L01-3. PMC: 2426630. DOI: 10.1529/biophysj.108.134122. View

20.

Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A . Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle. 2007; 6(13):1586-93. DOI: 10.4161/cc.6.13.4436. View